Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1058196 | 0.81 | — | — | |
| SCHEMBL31419536 | 0.81 | — | — | |
| SCHEMBL31170894 | 0.81 | — | — | |
| Bromide SCHEMBL31325357 | 0.81 | — | — | |
| SCHEMBL31255711 | 0.81 | — | — | |
| Hydrochloric Acid SCHEMBL4539889 | 0.81 | — | — | |
| Magnesium SCHEMBL12501204 | 0.81 | — | — | |
| Charcoal, Activated SCHEMBL7905790 | 0.81 | — | — | |
| SCHEMBL21177233 | 0.81 | — | — | |
| SCHEMBL6263893 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3801058-B1 | MOLECULE MIMICKING ANTI-OXIDANT ACTIVITY | BIONUCLEI (FR) | 2024-08-07 | — | — | EP | claimed |
| EP-3801058-B1 | MOLECULE MIMICKING ANTI-OXIDANT ACTIVITY | BIONUCLEI (FR) | 2024-08-07 | — | — | EP | disclosed |
| CN-107011382-A | A kind of tenofovir prodrug and preparation method thereof | 单爱莲 | 2017-08-04 | — | — | CN | disclosed |
| US-5597569-A | ABORTIFACIENT, IMMUNOMODULATOR, ANTI-TUMOR OR ANTI-VIRAL AGENT | BRISTOL-MYERS SQUIBB COMPANY (US) | 1997-01-28 | — | — | US | disclosed |
| EP-0206490-B1 | ANTIBIOTIC CLATHRATES | WARNER-LAMBERT COMPANY (US) | 1990-03-14 | — | — | EP | disclosed |
| US-4663316-A | Antibiotic clathrates and pharmaceutical compositions thereof | WARNER-LAMBERT COMPANY (US) | 1987-05-05 | — | — | US | disclosed |
| EP-0206490-A2 | Antibiotic clathrates | WARNER-LAMBERT COMPANY (US) | 1986-12-30 | — | — | EP | disclosed |